Literature DB >> 18342597

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Nanette Van Damme1, Daniel Goff, Chris Katsura, Rebecca L Jorgenson, Richard Mitchell, Marc C Johnson, Edward B Stephens, John Guatelli.   

Abstract

The HIV-1 accessory protein Vpu counteracts a host factor that restricts virion release from infected cells. Here we show that the interferon-induced cellular protein BST-2/HM1.24/CD317 is such a factor. BST-2 is downregulated from the cell surface by Vpu, and BST-2 is specifically expressed in cells that support the vpu phenotype. Exogenous expression of BST-2 inhibits HIV-1 virion release, while suppression of BST-2 relieves the requirement for Vpu. Downregulation of BST-2 requires both the transmembrane/ion channel domain and conserved serines in the cytoplasmic domain of Vpu. Endogenous BST-2 colocalizes with the HIV-1 structural protein Gag in endosomes and at the plasma membrane, suggesting that BST-2 traps virions within and on infected cells. The unusual structure of BST-2, which includes a transmembrane domain and a lumenal GPI anchor, may allow it to retain nascent enveloped virions on cellular membranes, providing a mechanism of viral restriction counteracted by a specific viral accessory protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342597      PMCID: PMC2474773          DOI: 10.1016/j.chom.2008.03.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  35 in total

1.  Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry.

Authors:  Miriam Vidal-Laliena; Xavier Romero; Sandra March; Vanessa Requena; Jordi Petriz; Pablo Engel
Journal:  Cell Immunol       Date:  2005-09-12       Impact factor: 4.868

2.  Visualization of retrovirus budding with correlated light and electron microscopy.

Authors:  Daniel R Larson; Marc C Johnson; Watt W Webb; Volker M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

3.  Involvement of a Golgi-resident GPI-anchored protein in maintenance of the Golgi structure.

Authors:  Xueyi Li; Dora Kaloyanova; Martin van Eijk; Ruud Eerland; Gisou van der Goot; Viola Oorschot; Judith Klumperman; Friedrich Lottspeich; Vytaute Starkuviene; Felix T Wieland; J Bernd Helms
Journal:  Mol Biol Cell       Date:  2007-01-24       Impact factor: 4.138

4.  The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release.

Authors:  Vasundhara Varthakavi; Rita M Smith; Kenneth L Martin; Aaron Derdowski; Lynne A Lapierre; James R Goldenring; Paul Spearman
Journal:  Traffic       Date:  2006-03       Impact factor: 6.215

5.  Influenza viruses select ordered lipid domains during budding from the plasma membrane.

Authors:  P Scheiffele; A Rietveld; T Wilk; K Simons
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

6.  Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation.

Authors:  Amanda L Blasius; Emanuele Giurisato; Marina Cella; Robert D Schreiber; Andrey S Shaw; Marco Colonna
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

7.  Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques.

Authors:  David R Hout; Melissa L Gomez; Erik Pacyniak; Lisa M Gomez; Sarah H Inbody; Ellyn R Mulcahy; Nathan Culley; David M Pinson; Michael F Powers; Scott W Wong; Edward B Stephens
Journal:  Virology       Date:  2005-08-15       Impact factor: 3.616

8.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

Authors:  F Margottin; S P Bour; H Durand; L Selig; S Benichou; V Richard; D Thomas; K Strebel; R Benarous
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

9.  HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.

Authors:  Stuart J D Neil; Scott W Eastman; Nolwenn Jouvenet; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2006-05-12       Impact factor: 6.823

10.  Quantitative membrane proteomics reveals new cellular targets of viral immune modulators.

Authors:  Eric Bartee; Ashley McCormack; Klaus Früh
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

View more
  643 in total

1.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.

Authors:  Amy J Andrew; Sandra Kao; Klaus Strebel
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.

Authors:  Sandrine Alais; Ricardo Soto-Rifo; Vincent Balter; Henri Gruffat; Evelyne Manet; Laurent Schaeffer; Jean Luc Darlix; Andrea Cimarelli; Graça Raposo; Théophile Ohlmann; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

4.  Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Authors:  Kei Sato; Naoko Misawa; Junko S Takeuchi; Tomoko Kobayashi; Taisuke Izumi; Hirofumi Aso; Shumpei Nagaoka; Keisuke Yamamoto; Izumi Kimura; Yoriyuki Konno; Yusuke Nakano; Yoshio Koyanagi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 5.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

6.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

7.  The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.

Authors:  Abdul A Waheed; Maya Swiderski; Ali Khan; Ariana Gitzen; Ahlam Majadly; Eric O Freed
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

8.  A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins.

Authors:  Gajendra W Suryawanshi; Alexander Hoffmann
Journal:  J Theor Biol       Date:  2015-09-16       Impact factor: 2.691

9.  Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses.

Authors:  Julia Bitzegeio; Marissa Sampias; Paul D Bieniasz; Theodora Hatziioannou
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 10.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.